Proteins Don't Belong to Companies

genomeweb
360dx

Proteins Don't Belong to Companies

Aug 01, 2008

The UK's High Court revoked Human Genome Sciences' patent on neutrokine-alpha, a protein involved in a number of inflammatory diseases, such as arthritis, asthma and chronic pulmonary disease, says the Financial Times.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Grifols Gets FDA Clearance for Procleix Zika Virus Assay
Curetis Posts 36 Percent Increase in H1 Revenues
Cancer Genetics Q2 Revenues Rise 7 Percent
NuGen, KeyGene Settle Patent Infringement Dispute
Top Five Articles on GenomeWeb Last Week: Illumina, Flatiron, PapGene, and More
Lucence Dx Signs Philippine Distribution Deal for Cancer Tests

The Scan

An RNAi Approval

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Keep It Going

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Stop It There

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

This Week in PLOS

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.

Main menu